Skip to main content
. 2022 Jun;10(11):645. doi: 10.21037/atm-21-5924

Table 2. Summary of the major developments regarding the role of NLRP3 inflammasome in acne vulgaris.

Items References
NLRP3 inflammasome participates in the pathogenesis of acne vulgaris (18,19,21,23-25,37)
NLRP3 inflammasome is a potential therapeutic target for acne vulgaris (8,16,18,19,21,25,35-37)
A variety of innate immune pathways are involved in the pathogenesis of acne vulgaris (15,39,40,42-50,52)
Adaptive immune responses in the development of acne vulgaris (14,55-61)

NLRP3, nucleotide oligomerization domain-like receptor family pyrin containing 3.